open access

Vol 9, No 2 (2006)
Published online: 2006-06-21
Submitted: 2012-01-23
Get Citation

Production and biological evaluation of [18F]-6-thia-14-fluoro-heptadecanoic acid

Amir R. Jalilian et al.
Nucl. Med. Rev 2006;9(2):108-113.

open access

Vol 9, No 2 (2006)
Published online: 2006-06-21
Submitted: 2012-01-23

Abstract


BACKGROUND: [18F]-6-thia-14-fluoro-heptadecanoic acid 3b, a free fatty acid, has been used in myocardial PET imaging. In order to establish an automated synthesis module for routine production in the country, a study was performed for optimization of the production conditions as well as making modifications.
MATERIAL AND METHODS: [18F]Benzyl-14-Fluoro-6-thia-heptadecanoate 2b was prepared in no-carrier-added (n.c.a) form from Benzyl-14-tosyloxy-6-thia-heptadecanoate 1 in one step at 90°C in Kryptofix2.2.2/[18F] with acetonitrile as the solvent followed by Silica column chromatography. The radiolabelled ester 2 was then hydrolysed to yield [18F]-6-thia-14-fluoro-heptadecanoic 3b. The final solution was concentrated using the C18 SPE system and administered to normal rats for biodistribution and co-incidence imaging studies.
RESULTS: The synthesis took 15 min with overall radiochemical yield of 15-25% (EOS) and chemical-radiochemical purity of more than 90%. Automation was performed using a two-pot synthesis. The best imaging time was shown to be 140-180 minutes post injection.
CONCLUSIONS: Using this procedure a fast, reliable, automated synthesis for the cardial PET tracer, i.e. [18F]FTHA, can be obtained without an HPLC purification step.

Abstract


BACKGROUND: [18F]-6-thia-14-fluoro-heptadecanoic acid 3b, a free fatty acid, has been used in myocardial PET imaging. In order to establish an automated synthesis module for routine production in the country, a study was performed for optimization of the production conditions as well as making modifications.
MATERIAL AND METHODS: [18F]Benzyl-14-Fluoro-6-thia-heptadecanoate 2b was prepared in no-carrier-added (n.c.a) form from Benzyl-14-tosyloxy-6-thia-heptadecanoate 1 in one step at 90°C in Kryptofix2.2.2/[18F] with acetonitrile as the solvent followed by Silica column chromatography. The radiolabelled ester 2 was then hydrolysed to yield [18F]-6-thia-14-fluoro-heptadecanoic 3b. The final solution was concentrated using the C18 SPE system and administered to normal rats for biodistribution and co-incidence imaging studies.
RESULTS: The synthesis took 15 min with overall radiochemical yield of 15-25% (EOS) and chemical-radiochemical purity of more than 90%. Automation was performed using a two-pot synthesis. The best imaging time was shown to be 140-180 minutes post injection.
CONCLUSIONS: Using this procedure a fast, reliable, automated synthesis for the cardial PET tracer, i.e. [18F]FTHA, can be obtained without an HPLC purification step.
Get Citation

Keywords

fatty acid; PET; fuorine-18; [18F]FTHA; quality control

About this article
Title

Production and biological evaluation of [18F]-6-thia-14-fluoro-heptadecanoic acid

Journal

Nuclear Medicine Review

Issue

Vol 9, No 2 (2006)

Pages

108-113

Published online

2006-06-21

Bibliographic record

Nucl. Med. Rev 2006;9(2):108-113.

Keywords

fatty acid
PET
fuorine-18
[18F]FTHA
quality control

Authors

Amir R. Jalilian et al.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl